On 2026-03-31 07:47:35 (Saudi Time), Saudi Pharmaceutical Industries and Medical Appliances Corp. announced its Annual financial results for the twelve months ended on December 31, 2025.

Element List	Explanation
The reason of the increase (decrease) in the sales/ revenues during the current year compared to the last year	The main reason for the increase in revenue during the current year compared the previous year is due to: - Increase in revenues from contract manufacturing service agreements by 283 % with the amount of SAR 46.8 million. - Increase in revenues from government sales by 32 % with the amount of SAR 84.2 million.
The reason of the increase (decrease) in the net profit during the current year compared to the last year is	The main reason for the increase in net profit during the current year compared the previous year is due to: - The reduction in selling and maketing expenses by 13% with the amount of SAR 43.6 million due to cost optimization. - The reduction in general and administrative expenses by 13% with the amount of SAR 36.6 million due to cost optimization. - The reduction in impairment charge on trade receivables by 43% with the amount of SAR 15.8 million due to improved collections - The increase in other income by 117% with the amount of SAR 21.4 million due to gain on disposal of fixed assets.
Statement of the type of external auditor's report	Unmodified opinion
Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion)	None
Reclassification of Comparison Items	Certain comparative figures for the last year have been reclassified to align with the presentation of the current year.
Additional Information	None
Attached Documents

Year-on-Year Performance Drivers

Sales increased 1.47% YoY to SAR 1,706.7 million, driven by a 283% surge in contract manufacturing service revenues (SAR 46.8 million increase) and a 32% rise in government sales (SAR 84.2 million increase). Net profit soared 652.65% to SAR 184.4 million, primarily due to cost optimization that reduced selling and marketing expenses by 13% (SAR 43.6 million) and general administrative expenses by 13% (SAR 36.6 million), alongside a 43% reduction in trade receivables impairment charges (SAR 15.8 million) from improved collections and a 117% increase in other income (SAR 21.4 million) from asset disposals.

Other Items

The external auditors issued an unmodified opinion with no additional comments, disclaimers, or adverse remarks noted. The company reports no accumulated losses, indicating a healthy capital position. Certain comparative figures from the previous year were reclassified to align with current year presentation standards.

Original announcement:

Attached PDF document link:

Important Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.